Treatment with mycophenolate mofetil in long-term renal transplant recipients: single-center experience in 28 patients

By Djeffal R.   Hiesse C.   Kriaa F.   Hafi A.   Boubenider S.   Ammor M.   Durrbach A.   Von Ey F.   Droupy S.   Hammoudi Y.   Eschwege P.   Benot G.   Charpentier B.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2765-2766

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients

By Abouna G.M.   Al Arrayed A.S.   Farid E.   Awad C.K.   Sharqawi S.A.-D.   Tantawi M.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4077-4078

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients

By Esmeraldo R.M.   Donadi M.O.R.C.   Oliveira M.L.   Ponte C.N.   Pinheiro P.M.A.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3007-3008

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients

By Chueh S.-C.   Huang C.-Y.   Lai M.-K.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1901-1902

Elsevier

Access to resources Recommend Favorite

The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid

By Kuriata-Kordek M.   Boratynska M.   Klinger M.   Wozniak M.   Urbaniak J.   Szyber P.   Patrzalek D.   Tupka D.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2985-2987

Elsevier

Access to resources Recommend Favorite